PubMed Papers

Pubmed Papers

Hormonal Effects

 

Moore E, Wisniewski A, Dobs A.
 
  Endocrine
treatment of transsexual people: a review of treatment regimens,
outcomes, and adverse effects.
J Clin Endocrinol Metab. 2003
Aug;88(8):3467-73.
 

Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H,
Seidell JC, Gooren LJ.
 
 
Effects of sex steroids on components of the insulin resistance
syndrome in transsexual subjects.
Clin Endocrinol (Oxf). 2003
May;58(5):562-71.
 

Van den Broecke R, Liu J, Van der Elst J, Dhont M.
 
  Timing of FSH-stimulation
and follicular development in cryopreserved human ovarian grafts.
Reprod Biomed Online. 2002
Jan-Feb;4(1):21-6.
 

Campo JM, Nijman H, Evers C, Merckelbach HL, Decker I.
 
  [Gender
identity disorders as a symptom of psychosis, schizophrenia in
particular]
Ned Tijdschr Geneeskd. 2001 Sep
29;145(39):1876-80. Dutch.
 

Pavon de Paz I, Monereo Megias S, Alameda Hernando C.
 
  [Treatment of
sex reassignment in transsexual patients]
Med Clin (Barc). 2000 Dec 9;115(20):783-8.
Review. Spanish. No abstract available.
 

Van Den Broecke R, Van Der Elst J, Liu J, Hovatta O, Dhont M.
 
  The
female-to-male transsexual patient: a source of human ovarian
cortical tissue for experimental use.
Hum Reprod. 2001 Jan;16(1):145-147.
 

Giltay EJ, Gooren LJ, Emeis JJ, Kooistra T, Stehouwer CD.
 
  Oral, but not
transdermal, administration of estrogens lowers tissue-type
plasminogen activator levels in humans without affecting
endothelial synthesis.
Arterioscler Thromb Vasc Biol. 2000
May;20(5):1396-403.
 

Cohen-Kettenis PT, Dillen CM, Gooren LJ.
 
  [Treatment of
young transsexuals in the Netherlands]
Ned Tijdschr Geneeskd. 2000 Apr
8;144(15):698-702. Review. Dutch.
 

Hage JJ, Dekker JJ, Karim RB, Verheijen RH, Bloemena E.
 
  Ovarian cancer
in female-to-male transsexuals: report of two cases.
Gynecol Oncol. 2000 Mar;76(3):413-5.
 

Becerra Fernandez A, de Luis Roman DA, Piedrola Maroto G.
 
  [Morbidity in
transsexual patients with cross-gender hormone self-treatment]
Med Clin (Barc). 1999 Oct 23;113(13):484-7.
Spanish.
 

New G, Duffy SJ, Harper RW, Meredith IT.
 
  Estrogen
improves acetylcholine-induced but not metabolic vasodilation in
biological males.
Am J Physiol. 1999 Dec;277(6 Pt 2):H2341-7.
 

Goh VH.
 
  Breast tissues
in transsexual women–a nonprostatic source of androgen
up-regulated production of prostate-specific antigen.
J Clin Endocrinol Metab. 1999
Sep;84(9):3313-5.
 

Schlatterer K, Bronisch T, Stalla GK.
 
  [Transsexuality–a
multidisciplinary problem. Which therapeutic methods proved to be
successful?]
MMW Fortschr Med. 1999 Jun 10;141(23):32-6.
German.
 

Hierl T, Borcsok I, Ziegler R, Kasperk C.
 
  [Osteo-anabolic
estrogen therapy in a transsexual man]
Dtsch Med Wochenschr. 1999 Apr
30;124(17):519-22. Review. German.
 

Cohen-Kettenis PT, van Goozen SH.
 
  Pubertal delay
as an aid in diagnosis and treatment of a transsexual adolescent.
Eur Child Adolesc Psychiatry. 1998
Dec;7(4):246-8.
 

Schlatterer K, Yassouridis A, von Werder K, Poland D, Kemper J,
Stalla GK.
 
  A follow-up
study for estimating the effectiveness of a cross-gender hormone
substitution therapy on transsexual patients.
Arch Sex Behav. 1998 Oct;27(5):475-92.
Review.
 

Schlatterer K, Auer DP, Yassouridis A, von Werder K, Stalla GK.
 
  Transsexualism
and osteoporosis.
Exp Clin Endocrinol Diabetes.
1998;106(4):365-8.
 

McFadden D, Pasanen EG, Callaway NL.
 
  Changes in
otoacoustic emissions in a transsexual male during treatment with
estrogen.
J Acoust Soc Am. 1998 Sep;104(3 Pt
1):1555-8.
 

Futterweit W.
 
  Endocrine
therapy of transsexualism and potential complications of long-term
treatment.
Arch Sex Behav. 1998 Apr;27(2):209-26.
Review.
 

Docter RF, Prince V.
 
  Transvestism:
a survey of 1032 cross-dressers.
Arch Sex Behav. 1997 Dec;26(6):589-605.
 

van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ.
 
  Mortality and
morbidity in transsexual subjects treated with cross-sex hormones.
Clin Endocrinol (Oxf). 1997
Sep;47(3):337-42.
 

Cohen-Kettenis PT, van Goozen SH.
 
  Sex
reassignment of adolescent transsexuals: a follow-up study.
J Am Acad Child Adolesc Psychiatry. 1997
Feb;36(2):263-71.
 

Buvat J, Lemaire A, Ratajczyk J.
 
  [Role of
hormones in sexual dysfunctions, homosexuality, transsexualism and
deviant sexual behavior: diagnostic and therapeutic consequences]
Contracept Fertil Sex. 1996
Nov;24(11):834-46. Review. French.
 

Schlatterer K, von Werder K, Stalla GK.
 
  Multistep
treatment concept of transsexual patients.
Exp Clin Endocrinol Diabetes.
1996;104(6):413-9. Review.
 

Gunasegaram R, Loganath A, Peh KL, Ratnam SS.
 
  Aromatization
of [4-14C]testosterone to [14C]estradiol-17 beta by testicular
tissue from male-to-female transsexuals on estrogen therapy.
Arch Androl. 1995 Sep-Oct;35(2):127-33.
 

Sigusch V.
 
  [Transsexual
wish and and cis-sexual defense]
Psyche (Stuttg). 1995
Sep-Oct;49(9-10):811-37. Review. German.
 

Burgess HE, Shousha S.
 
  An
immunohistochemical study of the long-term effects of androgen
administration on female-to-male transsexual breast: a comparison
with normal female breast and male breast showing gynaecomastia.
J Pathol. 1993 May;170(1):37-43.
 

Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW,
Gooren LJ.
 
  Influence of
sex hormones on plasma endothelin levels.
Ann Intern Med. 1993 Mar 15;118(6):429-32.
 

Lubbert H, Leo-Rossberg I, Hammerstein J.
 
  Effects of
ethinyl estradiol on semen quality and various hormonal parameters
in a eugonadal male.
Fertil Steril. 1992 Sep;58(3):603-8.
 

Pache TD, Hop WC, de Jong FH, Leerentveld RA, van Geldorp H, Van
de Kamp TM, Gooren LJ, Fauser BC.
 
  17 beta-Oestradiol,
androstenedione and inhibin levels in fluid from individual
follicles of normal and polycystic ovaries, and in ovaries from
androgen treated female to male transsexuals.
Clin Endocrinol (Oxf). 1992
Jun;36(6):565-71.
 

Valenta LJ, Elias AN, Domurat ES.
 
  Hormone
pattern in pharmacologically feminized male transsexuals in the
California State prison system.
J Natl Med Assoc. 1992 Mar;84(3):241-50.
 

Goh HH, Ratnam SS.
 
  Effect of
estrogens on prolactin secretion in transsexual subjects.
Arch Sex Behav. 1990 Oct;19(5):507-16.
 

Goh HH, Ratnam SS.
 
  Effects of
estrogens, clomiphene and castration in a male transsexual with as
compared to those without hypersecretion of gonadotropins.
Gynecol Endocrinol. 1990 Jun;4(2):127-41.
 

Godano A, Massara D, Grassi G, Genovese MG, Cavallotti GP,
Bocchini R.
 
  [Male
transsexualism and hormonal therapy: radiologic pictures of the
breast]
Arch Ital Urol Nefrol Androl. 1990
Mar;62(1):107-11. Italian.
 

Asscheman H, Gooren LJ, Eklund PL.
 
  Mortality and
morbidity in transsexual patients with cross-gender hormone
treatment.
Metabolism. 1989 Sep;38(9):869-73.
 

Damewood MD, Bellantoni JJ, Bachorik PS, Kimball AW Jr, Rock JA.
 
  Exogenous
estrogen effect on lipid/lipoprotein cholesterol in transsexual
males.
J Endocrinol Invest. 1989
Jul-Aug;12(7):449-54.
 

Prior JC, Vigna YM, Watson D.
 
  Spironolactone
with physiological female steroids for presurgical therapy of
male-to-female transsexualism.
Arch Sex Behav. 1989 Feb;18(1):49-57.
 

Spinder T, Spijkstra JJ, Gooren LJ, Burger CW.
 
  Pulsatile
luteinizing hormone release and ovarian steroid levels in
female-to-male transsexuals compared to heterosexual women.
Psychoneuroendocrinology.
1989;14(1-2):97-102.
 

Gilbert DA, Winslow BH, Gilbert DM, Jordan GH, Horton CE.
 
  Transsexual
surgery in the genetic female.
Clin Plast Surg. 1988 Jul;15(3):471-87.
Review.
 

Pritchard TJ, Pankowsky DA, Crowe JP, Abdul-Karim FW.
 
  Breast cancer
in a male-to-female transsexual. A case report.
JAMA. 1988 Apr 15;259(15):2278-80.
 

Gooren LJ, Assies J, Asscheman H, de Slegte R, van Kessel H.
 
  Estrogen-induced
prolactinoma in a man.
J Clin Endocrinol Metab. 1988
Feb;66(2):444-6.
 

Schulze C.
 
  Response of
the human testis to long-term estrogen treatment: morphology of
Sertoli cells, Leydig cells and spermatogonial stem cells.
Cell Tissue Res. 1988 Jan;251(1):31-43.
 

Cohen MS, Sanchez RL.
 
  Hemorrhagic
urethritis in female-to-male transsexual. Possible
androgen-related phenomena.
Urology. 1987 Dec;30(6):583-5.
 

Ratnam SS, Ilancheran A.
 
  Sex
reassignment surgery in the male transsexual.
Br J Hosp Med. 1987 Sep;38(3):204-8, 212-3.
 

Heresova J, Pobisova Z, Hampl R, Starka L.
 
  Androgen
administration to transsexual women. II. Hormonal changes.
Exp Clin Endocrinol. 1986 Dec;88(2):219-23.
 

Gooren L.
 
  The
neuroendocrine response of luteinizing hormone to estrogen
administration in the human is not sex specific but dependent on
the hormonal environment.
J Clin Endocrinol Metab. 1986
Sep;63(3):589-93.
 

van Bergeijk L, Gooren LJ, van Kessel H, Sassen AM.
 
  Effects of
naloxone infusion on plasma levels of LH, FSH, and in addition TSH
and prolactin in males, before and after oestrogen or
anti-oestrogen treatment.
Horm Metab Res. 1986 Sep;18(9):611-5.
 

van Bergeijk L, Gooren LJ, van Kessel H, Sassen AM.
 
  Effects of
continuous LHRH infusion on plasma levels of LH and FSH in males,
before and after oestrogen or anti-oestrogen treatment.
Horm Metab Res. 1986 Aug;18(8):558-64.
 

Miller N, Bedard YC, Cooter NB, Shaul DL.
 
  Histological
changes in the genital tract in transsexual women following
androgen therapy.
Histopathology. 1986 Jul;10(7):661-9.